Helen Jenkins
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Helen Jenkins
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA.
3
| Private Company | Pharmaceuticals: Major | 3 |
Saegis Pharmaceuticals, Inc.
Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Saegis Pharmaceuticals, Inc. developed drug therapeutics. Its phase II SGS742 clinical drug treated diseases such as mild cognitive impairment and attention deficit hyperactivity disorder. Its second SGS742 clinical trial provided coronary artery bypass surgery. The company was founded in 1999 and was headquartered in Half Moon Bay, CA.
1
| Extinct | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Helen Jenkins
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Applied Immune Sciences, Inc.
Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Medical Specialties | Corporate Officer/Principal | |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ATRECA, INC. | Biotechnology | Founder Founder | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Mimetix, Inc.
Mimetix, Inc. Pharmaceuticals: MajorHealth Technology Part of Symbollon Pharmaceuticals, Inc., Mimetix, Inc. develops pharmaceutical products with a focus on iodine drug therapy. Mimetix was acquired by Symbollon Pharmaceuticals, Inc. on July 01, 2004 for $0.80 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INNOVIVA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Corporate Officer/Principal Undergraduate Degree | |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Undergraduate Degree | |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sterling Winthrop Pharmaceuticals Research Center | Chief Tech/Sci/R&D Officer | ||
Stanford University School of Medicine | College/University | Doctorate Degree | |
Attenua, Inc.
Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Anagenex, Inc.
Anagenex, Inc. Packaged SoftwareTechnology Services Anagenex, Inc. is a company that uses high quality, large-scale data generation and AI to discover the next generation of small molecule medicines. Anagenex is based in San Francisco, CA. The company's platform leverages AI to design and synthesize hundreds of millions of target-specific compounds for testing in two weeks. The company's pipeline is focused on synthetic lethal oncology. The company was founded by Nicolas Tilmans and he has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Axalbion Therapeutics Ltd. has developed a drug candidate for several therapeutic applications. The private company is based in Wythenshawe, UK. The British company has evaluated new patented TRPM8 agonists, which are molecular transducers expressed in sensory neurons. The TRPM8 ion channel is expressed by approximately 10-15% of somatosensory neurons. Axalbion Therapeutics focuses on treating dry eye syndrome (DES), which is a disorder of the tear film due to tear deficiency. The company was founded in 2021, and the CEO is Michael M. Kitt. | Biotechnology | Chief Executive Officer | |
New York University Tandon School of Engineering
New York University Tandon School of Engineering Other Consumer ServicesConsumer Services New York University Tandon School of Engineering engages in the provision of educational services focusing on science and technology. Its degrees and programs include bachelor of science, master of science, doctor of philosophy, advanced certificate programs, a bridge program to NYU Tandon, and industry partner programs. The company was founded in 1854 and is headquartered in Brooklyn, NY. | College/University | Undergraduate Degree | |
New York University School of Medicine | College/University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 24 |
Schweiz | 2 |
Kanada | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 17 |
Consumer Services | 7 |
Finance | 3 |
Technology Services | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 12 |
Corporate Officer/Principal | 11 |
Undergraduate Degree | 4 |
Director/Board Member | 4 |
Founder | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael M. Kitt | 11 |
Ann C. Neale | 9 |
Tito Serafini | 8 |
Daniel Emerling | 5 |
- Börse
- Insiders
- Helen Jenkins
- Unternehmensverbindungen